TREM2 and hepatocellular carcinoma: In HCC specifically, TREM2’s modulation of macrophage activity within the liver can either promote a pro-tumorigenic environment conducive to cancer progression or enhance immune checkpoint blockade therapy, depending on its expression levels and the context of other immune modulators within the TME (34).